Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Safety, survival outcomes, and prognostic factors in conversion surgery for advanced gastric cancer: a sub-analysis of Japanese patients in the CONVO-GC-1 study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
   Article
2. Single centre experience with conversion surgery for advanced and metastatic gastric cancer in Slovakia.Scientific reports · 2025
   Article
3. Pathological Complete Response Achieved with XELOX Chemotherapy, HIPEC, and Anti-PD-1 Immunotherapy in Stage IV Gastric Adenocarcinoma with Peritoneal Metastasis: A Case Report and Review of the Literature.Journal of gastrointestinal cancer · 2024
   Review
4. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer.Cancers · 2023
   Article
5. Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: A propensity score matching analysis.Cancer medicine · 2023
   Article
6. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.Journal of personalized medicine · 2022
   Article
7. International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).Annals of gastroenterological surgery · 2022
   Article
8. Long-term survival after multidisciplinary treatments for advanced esophagogastric junction cancer.International cancer conference journal · 2021
   Article
9. The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot.Annals of gastroenterological surgery · 2021
   Review
10. Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial.Frontiers in pharmacology · 2021
    Article
11. Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer.Surgery today · 2020
    Article
12. The Effectiveness of Gastrectomy With Chemoradiotherapy Among Stage IV Gastric Adenocarcinoma: A Population-Based Analysis.Frontiers in oncology · 2020
    Article
13. Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2019
    Article
14. Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China.Journal of Cancer · 2019
    Article
15. Conversion Surgery for Stage IV Gastric Cancer.Frontiers in oncology · 2019
    Review
16. Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis.World journal of surgery · 2018
    Article
17. Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report.Oncology letters · 2018
    Article
18. Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases.Clinical journal of gastroenterology · 2018
    Article
19. The long-term survival of stage IV gastric cancer patients with conversion therapy.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2018
    Article
20. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.Surgery today · 2017
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as